Share-based Payment Arrangement, Expense of MARIZYME, INC. from 31 Dec 2020 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
MARIZYME, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2020 to 30 Sep 2024.
  • MARIZYME, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $20,794, a 76% decline year-over-year.
  • MARIZYME, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $185,392, a 74% decline year-over-year.
  • MARIZYME, INC. annual Share-based Payment Arrangement, Expense for 2023 was $526,597, a 72% decline from 2022.
  • MARIZYME, INC. annual Share-based Payment Arrangement, Expense for 2022 was $1,905,948, a 112% increase from 2021.
  • MARIZYME, INC. annual Share-based Payment Arrangement, Expense for 2021 was $898,444, a 51% decline from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

MARIZYME, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $185,392 $20,794 -$65,329 -76% 01 Jul 2024 30 Sep 2024 10-Q 05 Mar 2025 2024 Q3
Q2 2024 $250,721 $41,588 -$119,174 -74% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $369,895 $54,264 -$156,702 -74% 01 Jan 2024 31 Mar 2024 10-Q 28 May 2024 2024 Q1
Q4 2023 $526,597 $68,746 -$173,011 -72% 01 Oct 2023 31 Dec 2023 10-K/A 06 Feb 2025 2023 FY
Q3 2023 $699,608 $86,123 -$185,394 -68% 01 Jul 2023 30 Sep 2023 10-Q 05 Mar 2025 2024 Q3
Q2 2023 $885,002 $160,762 -$515,480 -76% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $1,400,482 $210,966 -$505,466 -71% 01 Jan 2023 31 Mar 2023 10-Q 28 May 2024 2024 Q1
Q4 2022 $1,905,948 $241,757 -$30,238 -11% 01 Oct 2022 31 Dec 2022 10-K/A 06 Feb 2025 2023 FY
Q3 2022 $1,936,186 $271,517 +$207,443 +324% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $1,728,743 $676,242 +$481,585 +247% 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023 2023 Q2
Q1 2022 $1,247,158 $716,432 +$348,714 +95% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $898,444 $271,995 01 Oct 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q3 2021 $64,074 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $194,657 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $367,718 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1

MARIZYME, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $526,597 -$1,379,351 -72% 01 Jan 2023 31 Dec 2023 10-K/A 06 Feb 2025 2023 FY
2022 $1,905,948 +$1,007,504 +112% 01 Jan 2022 31 Dec 2022 10-K/A 06 Feb 2025 2023 FY
2021 $898,444 -$934,848 -51% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
2020 $1,833,292 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.